A SOLIHULL charity has helped fund a major breakthrough in the fight against cancer.
Scientists at the Children’s Brain Tumour Research Centre, in The University of Nottingham, have found that a chromosomal abnormality in young patients can cause their brain tumour to behave more aggressively, leading to weaker survival rates.
They believe the discovery could lead to a new diagnostic test to identify the abnormality, leading to better targeted treatments with fewer debilitating side effects.
“This is an important step in being able to better treat children with these brain tumours,” said Dr John-Paul Kilday, who made the discovery alongside Professor Richard Grundy.
Their ground-breaking research has been made possible by Brain Tumour UK and the Joseph Foote Trust, which was founded by Andy and Judy Foote, from Solihull, in memory of their son Joseph who died of a brain tumour in 2007 aged nine.
Mr Foote said: “Childhood Ependymoma is a devastating condition for any family to have to endure.”
“Pioneering work such as this is key to giving patients and families the best possible outcomes in the wake of diagnosis and is an inspiring example of the work that Brain Tumour UK supports.”